Dr. Martens plc (LON:DOCS - Get Free Report) insider Kenny Wilson purchased 199 shares of the firm's stock in a transaction dated Wednesday, December 11th. The shares were acquired at an average cost of GBX 76 ($0.96) per share, with a total value of £151.24 ($191.71).
Kenny Wilson also recently made the following trade(s):
- On Thursday, September 26th, Kenny Wilson bought 30,000 shares of Dr. Martens stock. The stock was purchased at an average cost of GBX 55 ($0.70) per share, with a total value of £16,500 ($20,915.20).
Dr. Martens Stock Down 0.6 %
Shares of LON:DOCS traded down GBX 0.50 ($0.01) during midday trading on Friday, hitting GBX 76.55 ($0.97). The stock had a trading volume of 1,734,025 shares, compared to its average volume of 2,139,804. Dr. Martens plc has a 12 month low of GBX 49.32 ($0.63) and a 12 month high of GBX 100 ($1.27). The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 129.55. The business's 50-day simple moving average is GBX 59.41 and its 200-day simple moving average is GBX 67.56. The company has a market cap of £736.20 million, a P/E ratio of 1,100.71, a PEG ratio of 6.40 and a beta of 0.11.
Dr. Martens Cuts Dividend
The company also recently announced a dividend, which will be paid on Tuesday, April 8th. Investors of record on Thursday, March 6th will be paid a GBX 0.85 ($0.01) dividend. The ex-dividend date of this dividend is Thursday, March 6th. This represents a dividend yield of 1.47%. Dr. Martens's dividend payout ratio is presently 4,285.71%.
Dr. Martens Company Profile
(
Get Free Report)
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
